GRACE

cancergrace.org

 

GRACE
Avatar

IO for Unresectable Stage 3 NSCLC: Does Durvalumab Help Patients? What Are the Leading Treatment Options for Patients With Low / Negative PD-L1 Expression?

By GRACE FEATURING Millie Das
By GRACE FEATURING Millie Das
66 views
January 21, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip

Featured Video

17:48
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma With Mul…

Feat. R. Alter, A. Rezazadeh
Lung
06:18

New

Using Tarlatamab for Extensive Stage SCLC

GRACE

A. Desai, F. Abu Rous

16 views
05:40

New

Advancing Treatment in EGFR-Mutated NSCLC: Results From MARIPOSA2 an…

GRACE

A. Desai, F. Abu Rous

8 views
10:07

New

Advancing Treatment in EGFR-Mutated NSCLC: Results From FLAURA2 and …

GRACE

A. Desai, F. Abu Rous

49 views
17:13

Case-Based Panel: Managing EGFR Exon 21 L858R mNSCLC and Insights Fr…

GRACE

A. Saxena, E. Singhi, I. Preeshagul, N. Rohs

40 views
17:43

Case-Based Panel: Treating 70 y/o Female With SCLC and Insights From…

GRACE

E. Singhi, N. Rohs, A. Saxena, I. Preeshagul

115 views
18:45

Case-Based Panel: Managing EGFR Exon 19 Lung Cancer and Insights Fro…

GRACE

N. Rohs, A. Saxena, E. Singhi, I. Preeshagul

72 views
04:46

Repeat Biopsy in KRAS+ NSCLC

GRACE

J. Luo

88 views
05:27

Biopsies in Lung Cancer: Tumor vs. Liquid

GRACE

J. Luo

252 views
04:24

Treatment Strategies for KRAS+ NSCLC

GRACE

J. Luo

78 views
09:21

An Overview of KRAS+ NSCLC and Diagnostic Testing

GRACE

J. Luo

111 views
04:22

Targeted Therapy in Lung Cancer: Side Effects

GRACE

T. Patil

100 views
04:08

Targeted Therapy in Lung Cancer: The Importance of Biomarkers

GRACE

T. Patil

112 views
04:01

Lung Resection in Early Stage NSCLC: An Overview

GRACE

C. Jeffrey Yang

262 views
05:58

Future Goals of mNSCLC Treatment

GRACE

P. Iyengar

64 views
06:13

The NRG-LU Trial: Maintenance Systemic Therapy vs. Local Consolidati…

GRACE

P. Iyengar

54 views
06:14

Using Radiation to Improve Outcomes and QoL in Patients With mNSCLC

GRACE

P. Iyengar

9 views
02:41

Staging Disease: How Oncologists Stage NSCLC

GRACE

I. Dagogo-Jack, M. Das, C. Jeffrey Yang

602 views
03:19

Biomarkers in NSCLC

GRACE

I. Dagogo-Jack, M. Das, C. Jeffrey Yang

199 views
06:09

Perioperative vs. Preoperative Surgery in NSCLC

GRACE

I. Dagogo-Jack, M. Das, C. Jeffrey Yang

411 views
03:25

Antibody Drug Conjugates and How They Are Used in NSCLC

GRACE

L. Bazhenova

32 views
02:36

ADC Treatment in NSCLC

GRACE

L. Bazhenova

22 views
03:15

Bispecific Antibodies in Lung Cancer

GRACE

L. Bazhenova

19 views
02:52

Amivantamab in 1L Advanced NSCLC With EGFR exon 20 Insertion Mutatio…

GRACE

L. Bazhenova

38 views
05:47

Treatment Options for EGFR+ NSCLC

GRACE

I. Dagogo-Jack, N. Vokes

33 views
03:42

Surgical Options for Stage IV NSCLC With Brain Metastases: 60 y/o Wo…

GRACE

I. Dagogo-Jack, J. Reuss

12 views
06:02

Neoadjuvant Chemo +/- Nivo for Patients With Early Stage NSCLC: Case…

GRACE

I. Dagogo-Jack, J. Reuss

89 views
03:21

Treating Stage III NSCLC: Case-Based Panel Discussion

GRACE

I. Dagogo-Jack, K. Arbour

21 views
03:44

How Oncologists Stage Disease - Case-Based Panel Discussion: 50 y/o …

GRACE

I. Dagogo-Jack, J. Reuss, N. Vokes, K. Arbour

20 views
09:37

Is Broad NGS the Standard of Care in Advanced NSCLC?

GRACE

I. Dagogo-Jack, M. Marmarelis, A. Sacher, A. Hegde

134 views
05:27

Neoadjuvant Therapy vs. Adjuvant Therapy in NSCLC: What Is the Futur…

GRACE

J. West, E. Rodriguez, R. Shah, N. Duma

103 views
05:38

Surgical vs. Nonsurgical Treatment in Early NSCLC

GRACE

J. West, E. Rodriguez, R. Shah, N. Duma

89 views
07:28

Early Stage NSCLC: PD-L1 and Durvalumab

GRACE

J. West, E. Rodriguez, R. Shah, N. Duma

85 views
04:35

Testing in Potentially Resectable & Unresectable Locally Advanced NS…

GRACE

J. West, E. Rodriguez, R. Shah, N. Duma

96 views
22:49

The Need for Broad Molecular Testing for Driver Mutations in NSCLC

GRACE

J. Gainor

107 views
26:08

NSCLC Frontline Therapy for Uncommon Mutations: Overview of RET, NTR…

GRACE

J. Gainor

108 views
06:15

Expert Discussion on Targeted Therapy for mNSCLC: Can ALK Inhibitors…

GRACE

J. West

38 views
18:10

A Case of a NSCLC KRAS 71 y/o Female With Underlying Autoimmune Cond…

GRACE

S. Liu, J. Brahmer, B. Levy

76 views
15:42

Expert Analysis of 1L EGFR+ Advanced NSCLC Options: 1st Gen Gefitini…

GRACE

J. Weiss

205 views
10:33

Targeted Therapy for EGFR+ NSCLC: How Do We Think About Acquired Res…

GRACE

Z. Piotrowska

114 views
18:15

Targeted Therapy for EGFR+ NSCLC: What Are the Current Options Upon …

GRACE

Z. Piotrowska

104 views
05:41

ASCO Expert Discussion on Malignant Pleural Mesothelioma: Does Durva…

GRACE

J. West, H. Yu, D. Spigel

29 views
05:47

ASCO Roundtable on 2L Malignant Pleural Mesothelioma: How Encouragin…

GRACE

J. West, H. Yu, D. Spigel

103 views
10:25

IO for Unresectable Stage 3 NSCLC: Does Durvalumab Help Patients? Wh…

GRACE

M. Das

66 views
08:13

2020 ASCO Highlights on RT+ Chemo in LS-SCLC: Is There a Difference …

GRACE

J. West, H. Yu, D. Spigel

63 views
16:22

2020 ASCO ADAURA Trial Update on Adjuvant Osimertinib in EGFR+ NSCLC…

GRACE

H. Yu, D. Spigel, J. West

195 views
11:28

2020 ASCO Update on 1L Advanced NSCLC: Is Nivo + Ipi + Limited Cours…

GRACE

H. Yu, D. Spigel, J. West

110 views
11:22

2020 ASCO Update on Advanced NSCLC: What Is the Role for Nivolumab/I…

GRACE

H. Yu, D. Spigel, J. West

129 views
09:02

2020 ASCO Update on MET/RET+ NSCLC: How Promising Are Capmatinib & P…

GRACE

H. Yu, D. Spigel, J. West

119 views
08:25

2020 ASCO Update on HER2+ NSCLC: Is There a Promising Clinical Activ…

GRACE

H. Yu, D. Spigel, J. West

19 views
12:16

2020 ASCO Update on EGFR+ NSCLC: Does Upfront SBRT to Sites at Diagn…

GRACE

H. Yu, D. Spigel, J. West

571 views
08:16

ASCO 2020 Updates on PD-L1 NSCLC: Is Tiragolumab+Atezo Beneficial fo…

GRACE

J. West, H. Yu, D. Spigel

77 views
05:32

2020 Updates on SCLC: Have We Progressed in the Treatment of Relapse…

GRACE

T. Owonikoko

226 views
05:16

Liquid Biopsy in NSCLC: Does Adding Liquid Biopsy to Tissue Testing …

GRACE

C. Aggarwal

267 views
06:45

SCLC Updates: What Are the Leading Immunotherapy Options?

GRACE

S. Liu

314 views
05:38

Expert Discussion on mNSCLC: What Are the Leading Treatment Options …

GRACE

S. Liu

340 views
05:45

2020 Update on Molecular Abnormalities in NSCLC: How Do MET Exon 14 …

GRACE

J. Bauml

248 views
05:56

The Role of IO for NSCLC Patients With Driver Mutations: What Data D…

GRACE

B. Levy

192 views
07:43

2020 Update on Targeted Therapies in NSCLC PD-L1 Expression: What Ar…

GRACE

M. Das

112 views
07:55

Non-Small Cell Lung Cancer: Is Immunotherapy Safe for Frail Patients…

GRACE

M. Gubens

56 views
05:13

Does Immunotherapy Have Activity in Malignant Pleural Mesothelioma?

GRACE

M. Das

207 views
06:15

Non-Small Cell Lung Cancer: How Does a Positive HER2 Mutation Affect…

GRACE

J. West, J. Riess, S. Padda

18 views
06:03

ALK+ NSCLC With High PD-L1. What Is the First Line Treatment for Pot…

GRACE

J. West, J. Riess, S. Padda

137 views
06:00

What Is the Importance of MET Amplification Level in EGFR+ NSCLC Wit…

GRACE

C. McCoach, H. Wakelee, J. West

11 views
03:45

NSCLC EGFR Mutation Treated With Tagrisso: Progression While on Trea…

GRACE

C. McCoach, H. Wakelee, J. West

11 views
07:30

NSCLC EGFR Mutation and the FLAURA Trial: Is There a Difference in D…

GRACE

C. McCoach, H. Wakelee, J. West

15 views
08:20

EGFR + NSCLC: Is There a Place for Chemo and the Inclusion of Immuno…

GRACE

J. West, H. Wakelee, C. McCoach

746 views
04:14

EGFR Mutation and High and High PD-L1 in NSCLC: What is the Role of …

GRACE

C. McCoach, H. Wakelee, J. West

16 views
05:18

Non-Small Cell Lung Cancer: What Are the Recommended Treatments for …

GRACE

C. McCoach, H. Wakelee, J. West

123 views
05:04

NSCLC With EGFR Mutation: What Are the Treatment Options with Oligop…

GRACE

C. McCoach, H. Wakelee, J. West

11 views
07:12

NSCLC With EGFR Mutation: Is There a Place for Chemotherapy and an E…

GRACE

C. McCoach, H. Wakelee, J. West

525 views
05:52

NSCLC With EGFR Uncommon Exon 20 Mutation: Suggested Treatments, Tar…

GRACE

C. McCoach, H. Wakelee, J. West

20 views
04:20

The Challenges of Potential Pneumonitis Following Durvalumab in Stag…

GRACE

M. Gubens, J. West, M. Das

18 views
06:03

Would IO Be Beneficial for Stage 3 NSCLC Patient with PDL1-0 After S…

GRACE

M. Gubens, J. West, M. Das

135 views
08:02

Best Schedule for Durvalumab for Older Patient in Stage 3 NSCLC Afte…

GRACE

J. West, M. Gubens, M. Das

235 views
05:12

Unresectable NSCLC: What Is TMB and Does it Add Significant Benefit …

GRACE

M. Gubens, J. West, M. Das

470 views
08:50

Does Checkmate 227's Suggestion of an IO Combination of Ipi + Nivo O…

GRACE

M. Gubens, J. West, M. Das

131 views
10:58

Should Molecular Tests Be Considered in Stage 3 NSCLC and Would Outc…

GRACE

M. Gubens, J. West, M. Das

323 views
09:22

Case of 60 y/o Woman with ALK Positive Metastatic NSCLC: Approach to…

GRACE

S. Padda, J. Riess, J. West

197 views
06:14

Case of ALK Positive Patient with Asymptomatic Brain Metastases: Is …

GRACE

S. Padda, J. Riess, J. West

17 views
09:45

Treatment for NSCLC Patient Who Developed Resistance to ALK Inhibito…

GRACE

S. Padda, J. Riess, J. West

18 views
11:11

Is the Standard Treatment the Best Approach for Stage 3 Frail Patien…

GRACE

M. Gubens, J. West, M. Das

396 views
06:43

Should We Continue the ALK Inhibitor in NSCLC Patient with Brain Met…

GRACE

S. Padda, J. Riess, J. West

126 views
10:53

Is There a Role for Combination Therapies Like Chemo/Radio and IO fo…

GRACE

S. Padda, J. Riess, J. West

337 views
09:53

Stage 3 NSCLC - Standard Concurrent Chemo + Radiation, Followed by I…

GRACE

M. Gubens, J. West, M. Das

176 views
11:27

Stage 3 NSCLC: Is the Standard Treatment of Chemo and Radiation Foll…

GRACE

M. Gubens, J. West, M. Das

281 views
11:26

Case Based Discussion on Stage 3 NSCLC: Should We Do Molecular Tests…

GRACE

M. Gubens, J. West, M. Das

347 views
05:24

CancerGRACE's ASCO 2019 Update on Lung Cancer: How Promising is Lurb…

GRACE

J. West, B. Levy, C. Aggarwal

877 views
05:32

CancerGRACE's ASCO 2019 Update on Lung Cancer: Short Discussion on K…

GRACE

J. West, B. Levy, C. Aggarwal

178 views
06:02

CancerGRACE's ASCO 2019 Update on Lung Cancer: Circulating Tumor DNA…

GRACE

J. West, B. Levy, C. Aggarwal

95 views
05:53

CancerGRACE's ASCO 2019 Update on Lung Cancer: Retrospective Analysi…

GRACE

J. West, B. Levy, C. Aggarwal

99 views
03:55

CancerGRACE's ASCO 2019 Update on Stage IV NSCLC: New Targets - RET

GRACE

J. West, B. Levy, C. Aggarwal

148 views
06:33

CancerGRACE's ASCO 2019 Highlights and New Approaches in Stage IV NS…

GRACE

J. West, B. Levy, C. Aggarwal

283 views
07:14

CancerGRACE's ASCO 2019 Highlights and New Approaches in Stage IV NS…

GRACE

J. West, B. Levy, C. Aggarwal

69 views
06:33

CancerGRACE's 2019 ASCO Highlights in Advanced NSCLC: What is the Lo…

GRACE

J. West, B. Levy, C. Aggarwal

224 views
06:38

CancerGRACE's 2019 ASCO Highlights on Adjuvant Afatinib in Stage II …

GRACE

J. West, B. Levy, C. Aggarwal

470 views
07:26

CancerGRACE's 2019 ASCO Highlights on Stage I NSCLC Adjuvant Chemoth…

GRACE

J. West, B. Levy, C. Aggarwal

25 views
21:24

Is There a Role for IO in EGFR+ Metastatic Lung Cancer?

GRACE

H. Yu

4.8K views
47:56

Initial Treatment and Acquired Resistance in Advanced Lung Cancer & …

GRACE

J. Bauml, J. Sabari

208 views
21:58

Q&A on Targeted Therapies in Advanced Lung Cancer

GRACE

J. Bauml

15 views
19:19

Introduction to Next Generation Sequencing in Metastatic Lung Cancer…

GRACE

J. Bauml

626 views
23:26

EGFR Initial Treatment and Acquired Resistance in Advanced NSCLC

GRACE

H. Yu

179 views
09:30

Q&A on EGFR Initial Treatment and Acquired Resistance in Advanced NS…

GRACE

H. Yu

33 views
07:53

Optimal First Line Treatment of EGFR+ Advanced NSCLC: First and Seco…

GRACE

J. West

113 views
18:32

Optimal First Line Treatment of EGFR+ Advanced NSCLC: Osimertinib vs…

GRACE

J. West

558 views
17:04

Optimal First Line Treatment of EGFR+ Advanced NSCLC: Dacomitinib, E…

GRACE

J. West

676 views
17:10

Targeted Therapies in Advanced Lung Cancer: What is the Role of Rebi…

GRACE

H. Borghaei

462 views
26:54

Discussion/Q&A on Targeted Therapies in Advanced Lung Cancer

GRACE

H. Borghaei

24 views
15:23

Targeted Therapies in Metastatic NSCLC: Liquid Biopsies as a New Opt…

GRACE

C. Aggarwal

623 views
02:13

Immunotherapy in Stage lll NSCLC - The Pacific Trial and Imfinzi

GRACE

K. Kelly

168 views
01:54

Tumor Mutation Burden in Patients with Non-Squamous NSCLC: Current S…

GRACE

S. Patel

20 views
02:41

Evolving Standards for Molecular Testing in Advanced NSCLC

GRACE

S. Patel

21 views
02:05

Combinations of Immunotherapy Agents in Advanced NSCLC: Current Stat…

GRACE

S. Patel

18 views
02:17

The Basics of Managing Immune-Mediated Side Effects in NSCLC

GRACE

S. Patel

24 views
03:50

What Should Patients With Rapid Progression in Advanced NSCLC Throug…

GRACE

J. West

190 views
04:46

"Consolidation" Radiation After a Good Response to First Line Therap…

GRACE

J. West

15 views
06:57

Chemotherapy and Immunotherapy Combinations in Advanced Non-Squamous…

GRACE

J. West

164 views
05:39

Chemo Immuno Therapy Combinations in Advanced Squamous NSCLC

GRACE

J. West

179 views
07:13

Does Immunotherapy Work in Patients with Driver Mutations Like EGFR …

GRACE

J. West

237 views
04:09

EGFR TKI Gilotrif(Afatinib) in Metastatic Squamous NSCLC

GRACE

V. Velcheti

201 views
04:24

Lung Cancer Immunotherapy- Is There Anything Better than PDL1

GRACE

V. Velcheti

114 views
03:20

MET as a Target in Advanced NSCLC

GRACE

V. Velcheti

24 views
04:33

The Changing Landscape of 1L Treatment of ALK-Positive Advanced NSCL…

GRACE

A. Shaw

45 views
06:02

Patterns of Resistance in ALK Positive NSCLC

GRACE

A. Shaw

227 views
05:04

Controlling Brain Metastases in Patients with Molecular Driven Advan…

GRACE

A. Shaw

30 views
02:14

Immunotherapy for Previously Treated Patients with NSCLC

GRACE

K. Reckamp

16 views
04:50

New Options in Acquired Resistance for ALK+ Metastatic Non-small Cel…

GRACE

N. Pennell

235 views
03:45

The Role for Immunotherapy in Patients with a Driver Mutation Lung C…

GRACE

N. Pennell

19 views
03:35

Liquid Biopsies for Broad Genomic Testing in Lung Cancer

GRACE

N. Pennell

31 views
03:53

Liquid Biopsies for EGFR T790M Advanced NSCLC

GRACE

N. Pennell

17 views
02:45

The Role of Angiogenesis in Previously Treated NSCLC

GRACE

K. Reckamp

16 views
09:07

Advanced Non Squamous NSCLC, High PD-L1, No Mutation - Optimal 1st L…

GRACE

J. West, Z. Piotrowska, T. Owonikoko

219 views
12:59

Advanced Non Squamous NSCLC, Low PD-L1, No Mutation - Best Systemic …

GRACE

J. West, Z. Piotrowska, T. Owonikoko

236 views
11:09

Case Based Panel Discussion - Fit Patient Adv Squamous NSCLC Low Tum…

GRACE

J. West, Z. Piotrowska, T. Owonikoko

15 views
08:18

Lung Cancer Case Based Panel Discussion - EGFR and High PDL-1, Choos…

GRACE

J. West, Z. Piotrowska, T. Owonikoko

150 views
09:21

Case Based Panel Discussions - Metastatic Squamous NSCLC Low Tumor P…

GRACE

J. West, Z. Piotrowska, T. Owonikoko

15 views
08:17

Rapid Progression Lung Adenocarcinoma High PD-L1 - How Do You Treat?…

GRACE

J. West, Z. Piotrowska, T. Owonikoko

65 views
11:15

ASCO 2018 - Keynote 042 - Keytruda as a Single Agent Compared to Dou…

GRACE

K. Kelly, J. West, S. Patel

353 views
12:26

ASCO 2018 - Potential Showdown of Two Positive Trials? Keynote 407 a…

GRACE

K. Kelly, J. West, S. Patel

21 views
11:29

ASCO 2018 Keynote189 - Cisplatin or Carboplatin with Alimta & Keytru…

GRACE

K. Kelly, J. West, S. Patel

19 views
09:40

ASCO 2018 - Checkmate 227 - Combinations of Nivolumab and Ipilimumab…

GRACE

K. Kelly, J. West, S. Patel

21 views
07:35

ASCO 2018 - Will Taking Mod to High Dose Steroids Affect Lung Cancer…

GRACE

K. Kelly, J. West, S. Patel

14 views
09:11

ASCO 2018 - Tarceva or Tarceva with Avastin as 1st Line for EGFR Pos…

GRACE

K. Kelly, J. West, S. Patel

13 views
06:27

ASCO 2018 - Tarceva Combined with Carboplatin & Alimta - Given Upfro…

GRACE

K. Kelly, J. West, S. Patel

18 views
02:52

ASCO 2018 - Combining Metformin with Standard EGFR Therapy - Is the …

GRACE

K. Kelly, J. West, S. Patel

17 views
03:34

ASCO 2018 - Keynote 158 - Keytruda in Previously Treated, Now Relaps…

GRACE

K. Kelly, J. West, S. Patel

18 views
04:26

ASCO 2018 - Dream Study - Chemo with Imfinzi (durvalumab) for Mesoth…

GRACE

K. Kelly, J. West, S. Patel

28 views
25:01

OncTalk 2018 - Newer Technologies in Radiation - Local Therapies for…

GRACE

V. Mehta

17 views
21:07

OncTalk 2018 - Novel Indications for Local Therapy in Adv NSCLC - Lo…

GRACE

P. Iyengar

8 views
19:01

NSCLC - Local Therapies for Metastatic LC

GRACE

E. Vallieres

200 views
27:13

OncTalk 2018 - Systemic Therapies for Advanced NSCLC - Local Therapi…

GRACE

J. West

19 views
45:31

OncTalk 2018 - Panel Discussion and Q&A - Local Therapies for Metast…

GRACE

E. Vallieres, J. West, V. Mehta, P. Iyengar

16 views